Evidence map›Paper›PMID 31482734›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2019

Proteomics in gastroparesis: unique and overlapping protein signatures in diabetic and idiopathic gastroparesis.

Madhusudan Grover, Surendra Dasari, Cheryl E Bernard, Lakshmikanth L Chikkamenahalli, Katherine P Yates, Pankaj J Pasricha, Irene Sarosiek, Richard McCallum, Kenneth L Koch, Thomas L Abell and 10 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05981300 (GpCRC Pediatric Gastroparesis Registry 2), which is not on this map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05981300 recruitingnot on this mapstarted 2024, after this paper: background citation

GpCRC Pediatric Gastroparesis Registry 2: Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants With Symptoms of Gastroparesis

Typeobservational_patient_registrySponsorJohns Hopkins Bloomberg School of Public HealthRan2024 to 2027Enrolled216ConditionsGastroparesis, Gastroparesis-like Syndrome
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Guideline
  2. A pilot genome-wide association study meta-analysis of gastroparesis.United European gastroenterology journal · 2023
    Pooled it
  3. Dietary Interventions for Gastroparesis: A Systematic Review.Advances in nutrition (Bethesda, Md.) · 2022
    Pooled it
  4. Article
  5. Intestinal muscularis in health and disease.Communications biology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Common Pathophysiological Mechanisms and Treatment of Diabetic Gastroparesis.Journal of neurogastroenterology and motility · 2024
    Review
  12. Article
  13. Review
  14. The Human Gastric Juice: A Promising Source for Gastric Cancer Biomarkers.International journal of molecular sciences · 2023
    Review
  15. Ten controversies in gastroparesis and a look to the future.Neurogastroenterology and motility · 2023
    Review
  16. Article
  17. Article
  18. Progress in Gastroparesis - A Narrative Review of the Work of the Gastroparesis Clinical Research Consortium.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Review
  19. Gastroparesis.Gastroenterology · 2022
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

Madhusudan GroverEnteric NeuroScience Program, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5092-0831
Surendra DasariBiomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Cheryl E BernardEnteric NeuroScience Program, Mayo Clinic, Rochester, Minnesota.
Lakshmikanth L ChikkamenahalliEnteric NeuroScience Program, Mayo Clinic, Rochester, Minnesota.
Katherine P YatesJohns Hopkins University Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Pankaj J PasrichaJohns Hopkins School of Medicine, Baltimore, Maryland.
Irene SarosiekTexas Tech University Health Sciences Center, El Paso, Texas.
Richard McCallumTexas Tech University Health Sciences Center, El Paso, Texas.
Kenneth L KochWake Forest University, Winston-Salem, North Carolina.
Thomas L AbellUniversity of Louisville, Louisville, Kentucky.
Braden KuoMassachusetts General Hospital, Boston, Massachusetts.
Robert J ShulmanBaylor College of Medicine, Houston, Texas.
Simon J GibbonsEnteric NeuroScience Program, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5311-5993
Travis J McKenzieDepartment of Surgery, Mayo Clinic, Rochester, Minnesota.
Todd A KelloggDepartment of Surgery, Mayo Clinic, Rochester, Minnesota.
Michael L KendrickDepartment of Surgery, Mayo Clinic, Rochester, Minnesota.
James TonasciaJohns Hopkins University Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Frank A HamiltonNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Henry P ParkmanTemple University, Philadelphia, Pennsylvania.
Gianrico FarrugiaEnteric NeuroScience Program, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-3473-5235
Mayo Clinic · USJohns Hopkins University · USTexas Tech University · USBaylor College of Medicine · USMassachusetts General Hospital · USNational Institute of Diabetes and Digestive and Kidney Diseases · USTemple University · USUniversity of Louisville · USWake Forest University · US

Funding

Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2011 to 2020
$12.0M
PGpR2 Year 4 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4U24DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI David M Shade · 2017 to 2026
$11.7M
Subtypes of GastroparesisU01DK073974 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Baharak Moshiree · 2006 to 2026
$7.4M
Temple University Gastroparesis Clinical CenterU01DK073975 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI HENRY PAUL PARKMAN · 2006 to 2026
$7.4M
U of L Clinical Center to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis ConsortiumU01DK074007 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI Thomas Lyman Abell · 2006 to 2026
$7.0M
Molecular Approaches to Pathogenesis/Therapy in GastropaU01DK073983 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PANKAJ J PASRICHA · 2006 to 2026
$6.8M
The GpCRC Pediatric Gastroparesis Registry 2 (PGpR2): Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants with Symptoms of GastU01DK074035 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Irene Sarosiek · 2008 to 2026
$6.7M
Advancing Clinical Science in Pediatric GastroparesisU01DK112194 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Bruno Pedro Chumpitazi, Geoffrey A Preidis · 2016 to 2026
$5.3M
New England Gastropareis Consortium: Neurobiology of GastroparesisU01DK112193 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Helen Burton Murray, Braden Kuo · 2016 to 2026
$4.8M
"Barrier function alterations in post-infectious irritable bowel syndrome"K23DK103911 · NIDDK · MAYO CLINIC ROCHESTER · PI GROVER, MADHUSUDAN · 2015 to 2019
$804k
Mechanisms of barrier dysfunction in post-infection irritable bowel syndromeR03DK120745 · NIDDK · MAYO CLINIC ROCHESTER · PI GROVER, MADHUSUDAN · 2019 to 2020
$239k
NIDDK NIH HHS K23 DK103911NIDDK NIH HHS P30 DK089502NIDDK NIH HHS R03 DK120745NIDDK NIH HHS U01 DK073974NIDDK NIH HHS U01 DK073975NIDDK NIH HHS U01 DK073983NIDDK NIH HHS U01 DK074007NIDDK NIH HHS U01 DK074035NIDDK NIH HHS U01 DK112193NIDDK NIH HHS U01 DK112194NIDDK NIH HHS U24 DK074008
6 · The paper itself

Abstract

Macrophage-based immune dysregulation plays a critical role in development of delayed gastric emptying in diabetic mice. Loss of anti-inflammatory macrophages and increased expression of genes associated with pro-inflammatory macrophages has been reported in full-thickness gastric biopsies from gastroparesis patients. We aimed to determine broader protein expression (proteomics) and protein-based signaling pathways in gastric biopsies of diabetic (DG) and idiopathic gastroparesis (IG) patients. Additionally, we determined correlations between protein expressions, gastric emptying, and symptoms. Full-thickness gastric antrum biopsies were obtained from nine DG patients, seven IG patients, and five nondiabetic controls. Aptamer-based SomaLogic tissue scan that quantitatively identifies 1,305 human proteins was used. Protein fold changes were computed, and differential expressions were calculated using Limma. Ingenuity pathway analysis and correlations were carried out. Multiple-testing corrected

Indexed as

AdultAgedComplement C2Diabetes ComplicationsEndothelial CellsFemaleFibroblastsGastric EmptyingGastroparesisHumansMacrophagesMaleMiddle AgedProstaglandin-Endoperoxide SynthasesProtein Kinase CProtein Kinase C zetaComplement C2Prostaglandin-Endoperoxide SynthasesProtein Kinase CProtein Kinase C zetaProteomediabetesimmune cellsinflammationmacrophages

Identifiers

PMID31482734
PMCPMC6879892
OpenAlexW2971903657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.